Chiropractors in Hainesport, NJ Accepting Medicare
9 Chiropractors found. Showing 1 - 9
 Dr. Michael Fox, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2717 Marne Hwy, Hainesport, NJ 08036 Phone: 609-267-5550 |
Dr. John E Longo, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2717 Marne Highway, Hainesport, NJ 08036 Phone: 609-267-5550 Fax: 609-267-3535 |
 Dr. Mary Regina Laskowski, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2717 Marne Hwy, Hainesport, NJ 08036 Phone: 609-267-5550 Fax: 609-267-3535 |
 Christopher T. Taylor Dc, Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 1308 Rt 38, Hainesport, NJ 08036 Phone: 609-354-0330 Fax: 609-354-0331 |
Dr. Christopher Thomas Taylor, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1308 Rt 38 East, Hainesport, NJ 08036 Phone: 609-354-0330 Fax: 609-354-0331 |
Christopher T. Taylor, Dc Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1308 Route 38, Hainesport, NJ 08036 Phone: 609-354-0330 Fax: 609-354-0331 |
Hainesport Chiropractic Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 2717 Marne Highway, Hainesport, NJ 08036 Phone: 609-267-5550 Fax: 609-267-3535 |
Dr. Michael Stephen Kirk Jr., D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 208 Creek Crossing Blvd, Hainesport, NJ 08036 Phone: 856-727-8300 Fax: 856-727-8346 |
Hainesport Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 2717 Marne Hwy, Hainesport, NJ 08036 Phone: 609-267-5550 |
News Archive
Most prescriptions for buprenorphine are written by a small number of health care providers
Most prescriptions for the drug buprenorphine, used to treat opioid use disorder, are written by a small number of the health care providers, according to a new RAND Corporation study.
U.S. Marshals seize dietary supplements and unapproved drugs from Confidence
At the request of the U.S. Food and Drug Administration, U.S. Marshals recently seized dietary supplements and unapproved drugs from Confidence, Inc., of Port Washington, N.Y.
FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis
AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
Coffee consumption can reduce risk of ER-negative breast cancer in women
Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.
› Verified 3 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Podiatrists
Optometrists
Speech-Language Pathologists